American Gastroenterological Association
VC Fund
Bethesda, United States
American Gastroenterological Association is a VC fund in Bethesda focused on Medical and Health Care. The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include more than 16,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA, a 501(c6) organization, administers all membership and publicpolicy activities, while the AGA Institute, a 501(c3) organization, runs the organization’s practice, research and educational programs.On a monthly basis, the AGA Institute publishes two highly respected journals, Gastroenterology and Clinical Gastroenterology and Hepatology.The organization's annual meeting is Digestive Disease Week®, which is held each May and is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.The AGA Research Foundation provides digestive disease research grants on behalf of the AGA Institute.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries American Gastroenterological Association invests in
Stages American Gastroenterological Association invests in
Countries American Gastroenterological Association invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $8M–$18M
Investment Focus
Industry
- Medical 3 (100%)
- Health Care 3 (100%)
- Medical Device 2 (67%)
- Video 1 (33%)
- Mobile 1 (33%)
Stage
- Series A 2 (67%)
- Series C 1 (33%)
Country
- United States 2 (67%)
- New Zealand 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Eugene Chang
Chairman
|
Chairman | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function. | $18M / Series A / Oct 28, 2024 | ||
| Oshi Health is a virtual-first gastroenterology (GI) clinic that diagnoses, treats and remotely monitors digestive (GI) conditions. Patients work with Oshi Health's integrated care team of gastroenterologists and GI-specialized nurse practitioners, registered dietitians, behavioral psychologists and health coaches to determine the root causesof their symptoms and use a personalized care plan that includes medication, dietary interventions and stress/anxiety reduction to get symptoms under control. This yields improved health outcomes, quality of life, satisfaction with care and workplace productivity while reducing overall healthcare cost. | $60M / Series C / Oct 16, 2024 | ||
| Virgo provides the leading video capture, management, and AI analytics platform for endoscopy. We work with top medical centers including The Cleveland Clinic, Mount Sinai, Mass General, and UChicago and have built what we believe is the largest dataset of endoscopy videos – 2.5M+ procedures, growing by ~1M/yr. In early 2025, Virgo introducedEndoDINO, an AI foundation model for endoscopic imaging. Trained on data from over 130,000 procedure videos, EndoDINO achieves state-of-the-art performance in a wide range of GI endoscopy benchmarks. Most importantly, EndoDINO is capable of predicting placebo and drug response rates in patients with Inflammatory Bowel Disease from just a baseline colonoscopy video. This will enable significantly more efficient clinical trials and opens up possibilities for personalized medicine in IBD. | $8M / Series A / Jan 05, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does American Gastroenterological Association invest in?
American Gastroenterological Association invests primarily in Medical, Health Care and Medical Device startups, most often at Series A and Series C stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is American Gastroenterological Association's check size?
American Gastroenterological Association typically joins rounds of $8M–$18M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds American Gastroenterological Association participates in.
How do I contact American Gastroenterological Association?
Public channels for American Gastroenterological Association include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at American Gastroenterological Association?
The team at American Gastroenterological Association includes Eugene Chang (Chairman). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
